Marius Maxwell
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marius Maxwell.
American Journal of Human Genetics | 2003
Xiao Ping Zhou; Deborah J. Marsh; Carl Morrison; Abhik Ray Chaudhury; Marius Maxwell; Guido Reifenberger; Charis Eng
Lhermitte-Duclos disease (LDD), or dysplastic gangliocytoma of the cerebellum, is an unusual hamartomatous overgrowth disorder. LDD can be familial or, more commonly, sporadic. It has been only recently recognized that LDD may be associated with Cowden syndrome (CS). Over 80% of patients with CS carry germline mutations in PTEN. It remains unclear whether all cases of LDD, even without features of CS, are caused by germline PTEN mutation and whether somatic PTEN mutation occurs in sporadic LDD. We obtained paraffin-embedded LDD lesions from 18 unselected, unrelated patients and performed mutational analysis of PTEN. Overall, 15 (83%) of 18 samples were found to carry a PTEN mutation. All individuals with mutations were adult-onset patients, but the three without mutations were diagnosed at the ages of 1, 3, and 11 years. Germline DNA was available from six adult-onset cases, and all had germline PTEN mutations. Of these six, two had CS features, one did not have CS features, and three were of unknown CS status. Immunohistochemistry revealed that 75% of the LDD samples had complete or partial loss of PTEN expression accompanied by elevated phosphorylated Akt, specifically in the dysplastic gangliocytoma cells. These data suggest that the loss of PTEN function is sufficient to cause LDD. The high frequency and spectrum of germline PTEN mutations in patients ascertaining by LDD alone confirm that LDD is an important defining feature of CS. Individuals with LDD, even without apparent CS features, should be counseled as in CS.
Carbohydrate Research | 1996
Pericles Calias; Theofanis Galanopoulos; Marius Maxwell; Alex Khayat; Dana T. Graves; Harry N. Antoniades; Marc d'Alarcao
The antiproliferative flavonoid, quercetin, is limited in its pharmacological utility by its low water solubility. In this paper, we describe the synthesis of two quercetin analogues prepared by linking the hydroxyl group at the 3- or 5-position of the flavonoid to the 1-hydroxyl group of myo-inositol-2-phosphate via a succinate diester linkage. The resulting conjugates were found to have dramatically enhanced water solubility relative to quercetin; the 5-linked quercetin analogue 2 had a water solubility of > 300 mg/mL at 20 degrees C. Comparison of the in vitro cytotoxicity and antiproliferative activity of conjugate 2 with those of quercetin toward cultured human colon adenocarcinoma (SW480) and human glioblastoma (U87MG) cells indicated that this modification of quercetin does not significantly diminish its activity in these assays.
Neurosurgery | 1998
Marius Maxwell; Christopher Allegra; John MacGillivray; Dora W. Hsu; E. Tessa Hedley-Whyte; Peter N. Riskind; Joseph R. Madsen; Peter McL. Black
OBJECTIVE These studies evaluated the ability of transplanted pituitary cells to restore pituitary function in hypophysectomized rats. METHODS The pituitary glands of neonatal Lewis rats were rapidly removed, enzymatically dispersed, and stereotactically introduced into the third ventricle of hypophysectomized adult male Lewis rats. Four weeks after implantation, plasma levels of anterior pituitary hormones in implanted animals were compared with those of sham-transplanted control animals. RESULTS Plasma levels of prolactin, growth hormone, thyroid-stimulating hormone, and beta-endorphin were below the range of detection in 14 sham-operated animals. In implanted animals, restitution of serum prolactin occurred in 100% of the animals tested, with levels of 2.6 +/- 1.0 ng/ml (mean +/- standard error of the mean; normal, 2-4 ng/ml). Growth hormone was assayable in 71% of the animals, with a mean value of 29 +/- 13 ng/ml over all animals (normal, 1-100 ng/ml); thyroid-stimulating hormone was restored in 68%, with mean resting levels of 79 +/- 13 ng/ml (normal, 100-400 ng/ml); luteinizing hormone levels were found in 53%, with mean levels over all animals of 0.2 +/- 0.1 ng/ml (normal, 0.5-1.0 ng/ml); and beta-endorphin was restored in 45% to high resting levels of 163 +/- 31 pg/ml (normal, 20-30 pg/ml). A challenge with hypothalamic releasing factor and a cold stress test were performed on the animals that had received transplants. Positive hormone responses to both of these tests suggested sensitivity of the pituitary grafts to both endogenous and exogenous sources of stimulation. Histological sections of paraformaldehyde-fixed brains from implanted animals clearly demonstrated survival of clusters of grafted pituitary cells. Positive immunohistochemical staining for adrenocorticotropic hormone and thyroid-stimulating hormone was demonstrated in sections of the grafted tissue. CONCLUSION These data suggest survival of neonatal pituitary transplants in the third ventricle of adult hypophysectomized rats with concomitant restoration of anterior pituitary hormone function.
International Journal of Cancer | 1990
Marius Maxwell; Theofanis Galanopoulos; E. Tessa Hedley-Whyte; Peter McL. Black; Harry N. Antoniades
International Journal of Cancer | 1992
Harry N. Antoniades; Theofanis Galanopoulos; Janine Neville-Golden; Marius Maxwell
Cancer Research | 1991
Marius Maxwell; Stephen P. Naber; Hubert J. Wolfe; E. Tessa Hedley-Whyte; Theofanis Galanopoulos; Janine Neville-Golden; Harry N. Antoniades
Journal of Neurosurgery | 1992
Marius Maxwell; Theofanis Galanopoulos; Janine Neville-Golden; Harry N. Antoniades
Journal of Neurosurgery | 1993
Marius Maxwell; Theofanis Galanopoulos; Janine Neville-Golden; Harry N. Antoniades
Journal of Neurosurgery | 1999
Marius Maxwell; Lawrence F. Borges; Nicholas T. Zervas
Synapse | 1989
Scott A. Rivkees; Maamoun R. Chaar; Daniel F. Hanley; Marius Maxwell; Steven M. Reppert; George R. Uhl